The Contemporary Financial Landscape (A Reality Check)

In mid-2026, financial markets witnessed a prominent acquisition attempt when People Inc., led by billionaire Barry Diller, made a cash offer to buy the remaining stake (not owned) in MGM Resorts at $48.30 per share, valuing the company at over $18 billion. This offer faced initial resistance from MGM's management, which deemed the offer undervalued the company's "intrinsic value".

In such scenarios, boards of directors resort to defensive strategies to prevent a "hostile takeover" and force the buyer to negotiate.
One of the most notable and controversial strategies in financial and economic literature is the "poison pill" strategy.

What is a "Poison Pill"?

The "poison pill" is officially known in financial terminology as a "Shareholder Rights Plan".
It is a defensive mechanism included in the company's bylaws, aimed at making the company's shares financially unattractive to any entity attempting to acquire a controlling stake without prior approval from the board of directors.

The Mechanism:
The strategy relies on the principle of "Financial Dilution". Once the acquirer surpasses a predetermined ownership threshold (Trigger Point) – say 15% – the plan is activated, granting all shareholders (except the hostile acquirer) the right to purchase new shares at a significant discount to the market price.
This action immediately inflates the number of shares issued, resulting in:

  1. A sharp dilution of the acquirer's ownership percentage.
  2. Destruction of the market value of the shares they hold (Wealth Transfer).
  3. Raising the marginal cost of complete acquisition to prohibitive levels.

Economic Interpretation and Related Theories

For students of economics and finance, the "poison pill" is viewed not only as a legal measure but also as a phenomenon explained through fundamental economic theories:

Game Theory and Deterrence

The "poison pill" is not designed to be "swallowed" literally.
From a game theory perspective, it serves as a "Credible Threat".
Its goal is not to destroy the company's value but to change the incentive structure for the acquirer, forcing them to abandon the "open market purchase" strategy and come to the negotiation table with the board of directors.

The Agency Problem

This strategy raises extensive academic debate about the motivations of management (agents) and how they align with the interests of shareholders (principals), with economists divided into two hypotheses:

  • Bargaining Power Hypothesis:
    Proponents argue that the poison pill addresses the issue of "Information Asymmetry".
    The board has insider information about the true value of the company that exceeds what is reflected in the market price of the shares. The poison pill empowers management to reject lowball offers (as MGM's management believes about Barry Diller's offer) and negotiate for a higher "takeover premium" that maximizes shareholder wealth.
  • Entrenchment Hypothesis:
    Opponents argue that managers may use the poison pill to protect their positions and job security by thwarting any acquisition attempt, even if the deal offers excellent returns for shareholders. In this case, the poison pill destroys the company's value and increases agency costs.

Empirical Evidence and Market Reactions

Empirical studies in corporate finance indicate mixed results:

  1. Short-term Impact:
    The market typically reacts negatively (decline in share price) when a company announces the adoption of a poison pill plan in the absence of an existing acquisition offer, interpreting it as a signal of weak oversight over management and reducing the likelihood of acquisition.
  2. Long-term Impact (when an offer exists):
    Several studies (such as those by Comment & Schwert) have shown that companies with a poison pill that receive acquisition offers often succeed in securing much higher takeover premiums compared to companies without defenses, provided that the board is independent and acts in the interest of shareholders.

Back to MGM

In the case of MGM, the offer from People Inc. represents a real test for the board of directors. If MGM chooses to activate or threaten the "poison pill", sound economic analysis suggests that the ultimate goal should be to pressure Barry Diller to raise his initial price ($48.30), or to buy time to find an alternative buyer (White Knight), rather than simply obstructing the deal to maintain the company's independence without a clear plan to create future value beyond the current offer.